It is promising that HDAC inhibitors provide synergistic effects on JAK inhibitors in AD treatment (Quintás-Cardama et al., 2012; Rösler et al., 2018; Su et al., 2021). This evidence concerns the gene HDAC9 and Alzheimer disease.